Category

Blastoma

Blastoma

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications

Home Press release May 07, 2021 11:08 JST Source: Eisai Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications For Advanced Renal Cell Carcinoma and for Advanced Endometrial CarcinomaApplications Based on Progression-Free Survival, Overall Survival, and Objective Response…
bubmag
May 7, 2021
Blastoma

World-first discovery paves way to new cancer treatment

Credit: CC0 Public Domain Australian researchers have discovered a new way to target an aggressive childhood cancer, neuroblastoma, one of the most common and dangerous cancers in young children. The discovery may also have important implications for some other aggressive cancers in children, including certain brain tumours, as well as…
bubmag
March 26, 2021
Blastoma

Covid: 2,464 new cases, highest daily recoveries today

KUALA LUMPUR: Malaysia reported 2,464 Covid-19 infections today, the second time since Feb 9 that the daily case figures had dipped below the 3,000-mark. Health director-general Tan Sri Dr Noor Hisham Abdullah said the country’s Covid-19 infection tally now stands at 264,269, of which 49,490 are active cases. There was…
bubmag
February 14, 2021
Blastoma

Promising new approach to stop growth of brain cancer cells

IMAGE: Dr. Cheryl Arrowsmith is one of three senior authors publishing research on a different strategy to stop brain cancer cells from growing. view more  Credit: The Princess Margaret Cancer Foundation (Friday, February 12, 2021 - Toronto) -- Inhibiting a key enzyme that controls a large network of proteins important in…
bubmag
February 12, 2021
Blastoma

New drug targets for childhood cancer neuroblastoma identified

The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis of the disease. The researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH) and the Princess Máxima Center for Pediatric Oncology, discovered that all neuroblastomas arise from a single…
bubmag
February 5, 2021
Blastoma

A drug for diarrhea can kill aggressive cancer cells

New research suggests that a drug used to slow down an upset digestive tract may actually be useful in the treatment of cancer. The medication, called loperamide, is often used to treat diarrhea, but it can also induce the destruction of certain tumor cells.  Additional research is needed, but the…
bubmag
December 25, 2020
Blastoma

New insights into Glioblastoma invasiveness

One of the hallmarks of Glioblastoma (GBM), the most aggressive type of brain cancer, is its high invasive capacity, which leads to its expansion into the normal brain tissue. GBM cells insinuate themselves in the interstitial space of the neural tissue and migrate along blood vessels to more distant locations…
bubmag
December 11, 2020
Blastoma

New Drug Approved for Neuroblastoma Based on MSKCC Research

The US Food and Drug Administration (FDA) has granted accelerated approval for a new drug for certain patients with neuroblastoma based on response rate results in small open-label trials. The drug is naxitamab (Danyelza, Y-mAbs Therapeutics), a humanized monoclonal antibody that targets GD2 3F8, a disialoganglioside highly expressed on neuroblastomas. The product…
bubmag
November 26, 2020